FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, 25mM HEPES w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid

FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM), Low Glucose, 25mM HEPES w/o Sodium Pyruvate, Sodium Bicarbonate, Phenol Red: 1X Liquid

FluxMPS™ DCP-DMEMLH-PBR1X is a Microfluidics Suitable, ultra-filtered DMEM Low Glucose + HEPES formulation engineered for microphysiological systems (MPS), organ-on-a-chip (OoC), and microfluidic tissue models. A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration. Formulation: [+] L-Glutamine, [+] 25mM HEPES, [+] Calcium, [+] Magnesium, [+] Low Glucose | [-] Sodium Bicarbonate, [-] Phenol Red, [-] Sodium Pyruvate. HEPES (25 mM, pKa 7.3 at 37°C) provides robust CO₂-independent buffering.

• 0.04 µm final filtration — pore size well below typical mycoplasma dimensions (0.2–0.3 µm), supporting microfluidic channels below 100 µm
• Quadruple-stage sequential filtration: 0.1 µm Prefiltration I → 0.04 µm Final filtration I → 0.1 µm Prefiltration II → 0.04 µm Final filtration II (Polish)
• Endotoxin release specification < 0.05 EU/mL (LAL, USP <85>), controlled per manufacturing batch
• Formulation: [+] L-Glutamine, [+] 25mM HEPES, [+] Calcium, [+] Magnesium, [+] Low Glucose | [-] Sodium Bicarbonate, [-] Phenol Red, [-] Sodium Pyruvate
• Ultrapure Type 1 water (18.2 MΩ·cm), ISO 13485:2016 QMS, ISO Class 5 aseptic fill
• 25 mM HEPES buffer (pKa 7.3 at 37°C) — pH-stable without CO₂ incubation, suited to open-top chip architectures
• Custom pH, salts, and nutrient adjustments available on request

Engineered where standard media fails

Conventional 0.22 µm–filtered media passes mycoplasma-scale organisms, subvisible particulates, and aggregates that clog microfluidic channels and interfere with sensor signals. FluxMPS™ addresses these failure modes with a four-stage filtration train reaching a 0.04 µm final pore size. HEPES buffering removes CO₂ dependency for open-top chip architectures and atmospheric incubation.

Quadruple-stage filtration system

Four serial filtration stages reaching a final 0.04 µm polish under aseptic conditions — a repeated prefilter-plus-final-filter pair, run twice in series, engineered for microfluidic-channel-safe purity beyond conventional 0.22 µm filtered media.

1. 1

   0.1 µm Prefiltration I

   Removes large aggregates and particulates; protects the first 0.04 µm final filter cartridge.

2. 2

   0.04 µm Final filtration I

   Retains sub-micron particulates and microaggregates that pass a standard 0.22 µm filter.

3. 3

   0.1 µm Prefiltration II

   A second dedicated prefilter, protecting the second 0.04 µm final filter cartridge.

4. 4

   0.04 µm Final filtration II — Polish

   Ultimate polishing filter prior to aseptic fill & finish.

Designed for next-generation cell models

FluxMPS™ DCP-DMEMLH-PBR1X supports demanding platforms from single-channel microfluidic chips to multi-organ body-on-a-chip systems. The integrated 25 mM HEPES buffer makes it particularly suited to open-top microfluidic devices and atmospheric CO₂ environments.

Automated Bioreactors & Robotics

An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant is available on request for automated bioreactor perfusion and robotic liquid handlers.

• Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
• Valve & Sensor Protection: Reduces micro-fouling risk on solenoid valves and inline optical sensors
• Extended Perfusion Stability: Consistent nutrient delivery over weeks-long culture

Inquiry Required: Contact support@diagnocine.com for the 0.01 µm MPS Grade variant.

Analytical release specifications

Every lot released against the full specification matrix. CoA: support@diagnocine.com.

Full composition (mg/L)

This DMEM formulation provides amino acids and vitamins at 4× the concentration of standard Eagle's MEM. All 31 ingredients are verified per lot with CAS numbers for full raw-material traceability.

Manufacturing & compliance

Every FluxMPS™ product is manufactured and released under a multi-layer quality system spanning raw materials, in-process controls, and final-product testing.

How DCP-DMEMLH-PBR1X compares

FluxMPS™ DCP-DMEMLH-PBR1X vs. conventional 0.22 µm–filtered DMEM Low Glucose + HEPES formulations.

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

Frequently asked questions

Common questions about FluxMPS™ DCP-DMEMLH-PBR1X.

Supporting literature

Key peer-reviewed publications supporting Microfluidics Suitable, ultra-filtered media in organ-on-a-chip and microfluidic research.

1. Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
2. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
3. Ham RG. Clonal growth of mammalian cells in a chemically defined, synthetic medium. Proc Natl Acad Sci USA. 1965;53:288–293. doi:10.1073/pnas.53.2.288
4. Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407–420. doi:10.1038/s41551-019-0497-x
5. Jang KJ, et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol. 2013;5:1119–1129. doi:10.1039/c3ib40049b
6. Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588–3598. doi:10.1039/c3lc50217a
7. Wu Q, et al. Organ-on-a-chip: recent breakthroughs and future prospects. Biomed Eng Online. 2020;19:9. doi:10.1186/s12938-020-0752-0
8. Sung JH, et al. Microfabricated mammalian organ systems and their integration into models of whole animals and humans. Lab Chip. 2013;13:1201–1212. doi:10.1039/c3lc41017j